From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients
From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients is a paper indexed in PICO Portal from OpenAlex.
How many citations does From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients have?
From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients has 188 citations in the OpenAlex counts PICO Portal stores.
When was From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients published?
From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients has 2015 year in the PICO Portal index.
What is the open-access status of From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients?
From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients has hybrid oa status in the PICO Portal index.
What is the DOI of From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients?
The DOI for From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients is on the source record.
What is the PMID of From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients?
The PMID for From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients is on the source record.
What is the OpenAlex record for From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients?
The OpenAlex for From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients is on the source record.